C. difficile study in babies 0 to 2 years
Part of Infections clinical trials.
This study looks at C. difficile bacteria in babies up to 2 years old. It compares babies with C. difficile infection, carriers without symptoms, and healthy babies to understand how the bacteria affects them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is between 0 and 2 years old.
- Either your baby has tested positive for C. difficile (with or without diarrhea), or has tested negative with no stomach symptoms.
- You have medical records or a stool sample from your baby's past visits.
- Your baby's diarrhea is not caused by another infection like a virus.
- Your baby does not have a life-threatening health condition that affects their gut.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment called CMTS0929 for people with C. diff infection. It aims to see if the treatment can help clear the infection and improve symptoms.
This study is tracking patients with a confirmed C. difficile infection to understand how the body responds and how treatments work. You may be asked to do follow-up visits for up to 5 years.
This study looks at Clostridium difficile (C. diff) infections in babies under 2. It compares babies who have the infection with those who don't, using medical records to learn more about how it affects them.
This study looks at children with ongoing diarrhea to better understand the causes and find better ways to diagnose and treat it. It will use advanced testing to learn more about the condition.
This study follows pregnant women and their newborns to understand how a bacterium called Clostridioides difficile (C. difficile) colonizes and leaves the digestive tract in infants. Researchers want to identify factors that influence this process to better understand infant gut health and infection risk.
This trial studies how Clostridioides difficile (C. diff) affects healthy people by intentionally giving a controlled dose. The goal is to understand the infection better and help develop future treatments or vaccines.
Hear when a new Clostridioides Difficile Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.